ClinicalTrials HQ

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Active, not recruiting · NCT03813836 · Registry updated 2024-11-12
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCCHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaActive, not recruitingPhase 22024-11-12NCT03813836

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Merck Sharp & Dohme LLC650
University College, London222

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aberdeen Royal Infirmary (NHS Grampian)AberdeenUnited Kingdom1
Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust)BristolUnited Kingdom1
East and North Hertfordshire NHS TrustNorthwoodUnited Kingdom2
East Suffolk and North Essex NHS Foundation TrustIpswichUnited Kingdom3
Guy's and St Thomas' NHS Foundation TrustLondonUnited Kingdom26
Musgrove Park Hospital (Somerset NHS Foundation Trust)TauntonUnited Kingdom1
Queens Hospital (Barking, Havering and Redbridge University Hospitals NHS Trust)RomfordUnited Kingdom1
Royal Cornwall Hospital TrustTruroUnited Kingdom1
The Christie NHS Foundation TrustManchesterUnited Kingdom40
The Clatterbridge Cancer Centre NHS Foundation TrustMetropolitan Borough of WirralUnited Kingdom2
University College London HospitalLondonUnited Kingdom32
Western General Hospital (NHS Lothian)EdinburghUnited Kingdom1